1-7 of 7
Ajay K. Singh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

Open Access
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023 , Nephrology
Iain C. Macdougall, Amy M. Meadowcroft, Allison Blackorby, Borut Cizman, Alexander R. Cobitz, Sergio Godoy, Vivekanand Jha, Kirsten L. Johansen, Gearoid McMahon, Gregorio T. Obrador, Muh Geot Wong, Ajay K. Singh
Journal: American Journal of Nephrology
Am J Nephrol (2023) 54 (1-2): 1–13.
https://doi.org/10.1159/000528696
Published Online: 23 May 2023
View article titled, Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)
Open the PDF for Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D) in another window
Journal Articles

Debate: Are HIF Stabilizers a Viable Alternative to ESAs in the Management of Anemia in CKD? PRO

Free
Subject Area:
Nephrology
Ajay K. Singh
Journal: American Journal of Nephrology
Am J Nephrol (2022) 53 (5): 361–365.
https://doi.org/10.1159/000523948
Published Online: 21 June 2022
View article titled, Debate: Are HIF Stabilizers a Viable Alternative to ESAs in the Management of Anemia in CKD? PRO
Open the PDF for Debate: Are HIF Stabilizers a Viable Alternative to ESAs in the Management of Anemia in CKD? PRO in another window
Journal Articles

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial

Available to Purchase
Subject Area:
Nephrology
Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Toto, Patrick Parfrey
Journal: American Journal of Nephrology
Am J Nephrol (2018) 46 (6): 488–497.
https://doi.org/10.1159/000485326
Published Online: 14 December 2017
View article titled, Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
Open the PDF for Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial in another window
Journal Articles

A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

Available to Purchase
Subject Area:
Nephrology
Matthew R. Weir, Pablo E. Pergola, Rajiv Agarwal, Jeffrey C. Fink, Nelson P. Kopyt, Ajay K. Singh, Jayant Kumar, Susanne Schmitt, Gregor Schaffar, Anita Rudy, Jim P. McKay, Radmila Kanceva
Journal: American Journal of Nephrology
Am J Nephrol (2017) 46 (5): 364–370.
https://doi.org/10.1159/000481736
Published Online: 30 October 2017
View article titled, A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease
Open the PDF for A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease in another window
Journal Articles

Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease

Available to Purchase
Subject Area:
Nephrology
Peter A. McCullough, Huiman X. Barnhart, Jula K. Inrig, Donal Reddan, Shelly Sapp, Uptal D. Patel, Ajay K. Singh, Lynda A. Szczech, Robert M. Califf
Journal: American Journal of Nephrology
Am J Nephrol (2013) 37 (6): 549–558.
https://doi.org/10.1159/000351175
Published Online: 25 May 2013
View article titled, Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease
Open the PDF for Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease in another window
Journal Articles

Debate: PRO Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed?

Free
Subject Area:
Nephrology
Ajay K. Singh
Journal: American Journal of Nephrology
Am J Nephrol (2010) 31 (6): 552–556.
https://doi.org/10.1159/000314628
Published Online: 21 May 2010
View article titled, Debate: PRO Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed?
Open the PDF for Debate: PRO Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed? in another window
Journal Articles

Rebuttal: PRO Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed?

Available to Purchase
Subject Area:
Nephrology
Ajay K. Singh
Journal: American Journal of Nephrology
Am J Nephrol (2010) 31 (6): 561–562.
https://doi.org/10.1159/000314630
Published Online: 21 May 2010
View article titled, Rebuttal: PRO Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed?
Open the PDF for Rebuttal: PRO Position. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed? in another window